Work

Supplementary Figure S6 from TNIK Overexpression Is Sufficient for Chemoradiation Resistance in Limited-Stage Small Cell Lung Cancer

Year: 2026
Type: supplementary-materials
Abstract: Supplementary Figure S6 shows clonogenic survival of TNIK-high H446 and TNIK-low DMS114 cells treated with vehicle, 0.5 uM cisplatin, 300 nM NCB-0846, or both for 48h before receiving radiation.
Subfield: Oncology
Field: Medicine
Open Access status: gold
OpenAlex ID: W7204992463
Cites:
Cited by:
Related to: